The Different Forms of Peptides: Injectables, Capsules, Nasal Sprays, Topicals, and More

Peptides are short chains of amino acids that participate in an enormous range of biological processes. As peptide science has advanced, researchers and pharmaceutical developers have faced an important question: What is the best way to deliver a peptide to its intended destination?

Unlike many conventional small-molecule compounds, peptides can be relatively large, water-soluble molecules that do not readily cross biological membranes. They can also be vulnerable to enzymes that break proteins and peptides apart. These characteristics make the method of delivery particularly important.

Consequently, peptides are available or being investigated in numerous forms, including lyophilized powders for injection, prefilled injectable solutions, tablets and capsules, nasal sprays, sublingual preparations, topical products, inhaled formulations, and newer delivery technologies such as microneedle patches.

There is no universally “best” form. Each has advantages and disadvantages, and the appropriate delivery method depends heavily on the particular peptide and what researchers or an approved therapy are attempting to accomplish.

Why Peptide Form Matters

The route used to deliver a peptide can dramatically influence how much reaches its target.

Peptides administered orally, for example, must survive stomach acid, digestive enzymes, intestinal mucus, and the intestinal epithelial barrier before reaching systemic circulation. These obstacles explain why conventional oral delivery is difficult for many peptides.

Injection bypasses most of those gastrointestinal barriers, which is one reason injectable formulations remain predominant among approved peptide therapeutics. A review of approved therapeutic peptide products found injectable routes represented approximately 78% of administration routes evaluated.

Alternative delivery methods attempt to balance bioavailability, stability, convenience, precision, and ease of use.

1. Lyophilized Peptides for Injection

One of the most recognizable forms of research peptide is a small glass vial containing white or off-white lyophilized material.

Lyophilization, or freeze-drying, removes water from a peptide formulation under carefully controlled conditions. The peptide remains in a dry form until it is appropriately reconstituted for its intended laboratory application.

Subcutaneous injection is particularly common among approved injectable peptide therapies, although intravenous and intramuscular routes are also used depending on the medication.

Advantages

The greatest advantage is bioavailability. Injection avoids the destructive environment of the gastrointestinal tract and the difficult intestinal absorption process.

Lyophilization can also improve storage stability for suitable formulations because the peptide does not remain continuously exposed to water.

Another advantage is precise control. Researchers can accurately prepare known concentrations and volumes for experimental applications.

Disadvantages

Injectable preparations require considerably more handling than swallowing a tablet or using a nasal spray.

Sterile technique and appropriate equipment become important considerations. For therapeutic applications, injections may also produce discomfort or injection-site reactions and can reduce patient acceptance, particularly when repeated frequently.

2. Ready-to-Use Liquid Injectables

Not every injectable peptide is supplied as lyophilized powder.

Some approved peptide medications are manufactured as stable liquid formulations and may be supplied in vials, cartridges, or prefilled injection devices.

The major advantage is convenience. There is no reconstitution step, and commercially manufactured delivery devices can make administration considerably simpler.

The tradeoff is that maintaining a peptide in solution can present stability challenges. Liquid formulations may require carefully controlled pH, stabilizing excipients, temperature control, and specialized packaging.

For researchers and pharmaceutical developers, deciding between a liquid and lyophilized formulation therefore depends heavily upon the stability characteristics of the individual peptide.

3. Peptide Tablets and Capsules

For most people, oral administration represents the easiest and most familiar way of taking a medication.

A tablet or capsule is portable, needle-free, convenient, and generally easy to use consistently. These advantages make oral peptide delivery extremely attractive.

Unfortunately, the digestive system is specifically designed to break proteins and peptides into smaller components.

Peptides taken orally may encounter acidic stomach conditions followed by numerous digestive enzymes. Even when the peptide survives those conditions, its size, charge, and hydrophilic characteristics can make passage through the intestinal wall difficult.

Advantages

Oral products are highly convenient, portable, familiar, and needle-free. They may also simplify storage and administration compared with injectable products.

Disadvantages

The biggest limitation is generally bioavailability.

Traditional peptides can be degraded before meaningful quantities reach circulation, while the intestinal wall itself represents another substantial barrier.

Modern pharmaceutical technology is attempting to overcome these problems through specialized coatings, enzyme inhibitors, absorption enhancers, chemical modifications, and other formulation strategies.

As a result, the statement that “peptides cannot be taken orally” is too broad. Some peptide therapeutics can be administered orally, but successful oral peptide delivery generally requires the peptide and formulation to be specifically engineered for that route.

4. Peptide Nasal Sprays

Intranasal delivery offers an interesting middle ground between injection and oral administration.

A peptide formulated as a nasal spray is deposited onto the mucosal surfaces inside the nose, where absorption may occur.

The nasal cavity has a substantial vascular supply, and intranasal administration avoids gastrointestinal degradation and conventional hepatic first-pass exposure.

Advantages

Nasal sprays are needle-free, fast, portable, and convenient. They can also provide relatively rapid absorption for appropriately formulated molecules.

This route eliminates the inconvenience associated with injections while avoiding many gastrointestinal problems associated with tablets and capsules.

Disadvantages

The nasal cavity can only accommodate relatively small quantities of formulation.

Mucus and natural mucociliary clearance can remove material before absorption occurs. Peptide-degrading enzymes are also present, and absorption can vary between individuals.

Nasal irritation is another possible limitation, particularly when formulations require absorption-enhancing ingredients.

Consequently, a peptide being sold as a nasal spray does not automatically mean that nasal delivery provides adequate bioavailability. The individual peptide and formulation must be evaluated.

5. Sublingual and Buccal Peptides

Sublingual products are placed beneath the tongue, while buccal formulations are designed for contact with the mucosal surfaces of the cheek.

Both approaches attempt to deliver a peptide through the highly vascular tissues of the mouth rather than sending it through the entire digestive tract.

Advantages

These methods are needle-free and convenient.

They may bypass some gastrointestinal degradation and potentially avoid at least part of conventional first-pass metabolism.

Buccal delivery can also provide relatively rapid access through the oral mucosa for molecules capable of crossing it.

Disadvantages

Peptides still have difficulty crossing biological membranes.

Saliva can dilute the formulation, and swallowing part of the material may redirect it into the gastrointestinal tract.

Taste, mucosal irritation, limited dose capacity, and inconsistent absorption can also present challenges.

The FDA recognizes both sublingual and transmucosal routes as distinct administration routes.

6. Topical Peptide Creams, Gels, and Serums

Peptides have also become increasingly familiar as ingredients in topical products, particularly cosmetic and dermatological formulations.

The concept is straightforward: instead of delivering the peptide throughout the body, the formulation is placed directly onto the skin.

Advantages

Topical application is simple, needle-free, and particularly attractive when the desired activity is localized to the skin.

A topical formulation can potentially concentrate exposure around the application area while limiting systemic exposure.

Disadvantages

Skin is specifically designed to keep foreign substances out.

The outermost layer—the stratum corneum—is an extremely effective barrier, and conventional passive transdermal delivery is difficult for molecules as large as most peptides.

Therefore, simply putting a peptide into a cream does not mean substantial quantities will penetrate deeply or reach systemic circulation.

Formulation technology becomes extremely important.

7. Transdermal and Microneedle Peptide Delivery

Transdermal peptide delivery attempts to move the peptide through the skin rather than simply producing a surface effect.

Traditional patches work extremely well for certain small molecules, but peptides present a much greater challenge because of their molecular size and physicochemical characteristics.

Microneedle technology represents one potential solution.

Microneedle patches contain extremely small projections that penetrate the skin’s outer barrier and deposit material into the viable epidermis or upper dermis.

Advantages

Microneedles potentially combine some advantages of injection with the convenience of a patch.

They may improve penetration compared with conventional topical products while reducing the inconvenience associated with traditional hypodermic needles.

Disadvantages

Dose capacity remains a significant limitation, and manufacturing these systems is considerably more complicated than producing an ordinary cream or tablet.

Research reviews suggest that microneedles may currently be particularly promising for applications such as vaccines and immunotherapies, while systemic chronic peptide delivery continues to present challenges.

8. Inhaled Peptides

The lungs provide another possible route.

Pulmonary tissue contains an enormous surface area, extensive blood supply, and a relatively thin epithelial barrier. Inhalation also avoids conventional gastrointestinal degradation and hepatic first-pass metabolism.

Advantages

Inhalation is needle-free and potentially capable of relatively rapid absorption.

The lungs can provide a large absorptive surface compared with nasal or buccal tissues.

Disadvantages

Delivering a consistent dose into the lungs can be difficult.

Particle size, inhalation technique, respiratory health, device design, and deposition location can all influence how much material reaches the intended area.

Safety is particularly important because repeated exposure of lung tissue to formulations or excipients must be carefully evaluated.

Which Peptide Form Is Best?

There isn’t one answer.

For a peptide requiring reliable systemic exposure, an injectable formulation may provide major pharmacokinetic advantages.

For another peptide, local topical activity might be the objective, making systemic absorption unnecessary.

For long-term therapeutic use, convenience can become enormously important. A formulation that produces excellent bioavailability but is difficult or uncomfortable to use repeatedly may have disadvantages compared with a less invasive delivery system.

This creates a balancing act between:

Bioavailability + Stability + Convenience + Precision + Safety + Intended Target

Researchers and pharmaceutical developers increasingly attempt to optimize all of these factors rather than concentrating exclusively on one.

The Future of Peptide Delivery

Peptide delivery technology is evolving rapidly.

Researchers are investigating advanced oral delivery systems, nanoparticles, permeation enhancers, chemical modifications, long-acting injectable depots, implants, transdermal technologies, and microneedle systems.

The objective is often the same: obtain the biological specificity offered by peptides while making them easier and more reliable to deliver.

This is particularly significant because peptides occupy an unusual middle ground. They can offer biological specificity that is difficult to achieve with conventional small molecules, but their size and susceptibility to degradation create delivery problems that ordinary tablets rarely encounter.

For now, injectable formulations remain extremely important, but tablets, capsules, nasal sprays, sublingual formulations, topical products, inhaled systems, and emerging technologies demonstrate that “peptide” does not describe a single type of product or delivery system.

The form matters—and sometimes it matters just as much as the peptide itself.

Important note: A particular peptide being commercially offered as a capsule, nasal spray, topical product, or injectable does not by itself demonstrate that the formulation has been clinically validated, approved for human use, or shown to provide meaningful bioavailability. Approved therapeutic peptides should be used according to their authorized labeling, while research compounds should be handled according to applicable laboratory and regulatory requirements.